Status:

NOT_YET_RECRUITING

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Lead Sponsor:

Wake Forest University Health Sciences

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Malignant Solid Neoplasm

Hematopoietic Neoplasms

Eligibility:

All Genders

15+ years

Brief Summary

This study evaluates how adolescent and young adults with cancer in the U.S. and their loved ones respond to questions that will later be used with people who may have cancer and other chronic health ...

Detailed Description

PRIMARY OBJECTIVES: * To refine patient-reported outcome assessment tools of body image, fertility, and financial burden for PROMIS and evaluate assumptions for IRT consistent with PROMIS Scientific ...

Eligibility Criteria

Inclusion

  • AYAs with a cancer history (AYA-C)
  • Young adults between the ages of 15 to 39 years;
  • First diagnosed with cancer during 15 to 39 years of age;
  • Able to read and understand English;
  • Live in the United States;
  • Have a new cancer diagnosis and are receiving curative treatment OR are currently 0 to 10 years post-treatment.

Exclusion

  • Diagnosed with basal cell skin cancer; or
  • Are currently receiving hospice care.
  • AYAs General Population (AYA-GP)
  • Inclusion Criteria:
  • Young adults between the ages of 15 to 39 years;
  • Able to read and understand English; and
  • Live in the United States.
  • Caregivers of AYAs with cancer (AYA-Cg)
  • Inclusion Criteria:
  • 18 years of age or older;
  • Able to read and understand English;
  • Live in the United States;
  • Have a child/ward/partner for whom they have provided care, AND
  • Their child/ward/partner is 15 to 25 years of age and meets the other eligibility criteria as an AYA participant with a cancer history (described above).

Key Trial Info

Start Date :

January 1 2026

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2028

Estimated Enrollment :

3000 Patients enrolled

Trial Details

Trial ID

NCT06897137

Start Date

January 1 2026

End Date

January 1 2028

Last Update

December 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, United States, 27157